Global Healthy Living Foundation Says Hims & Hers Health Super Bowl Ad Omits Risks of Weight Loss Drug

GHLF Urges Greater Transparency and Patient Protections UPPER NYACK, N.Y.–(BUSINESS WIRE)–The Global Healthy Living Foundation (GHLF), a leading worldwide patient advocacy organization, is raising concerns about the lack of full disclosure in the Hims & Hers Health Super Bowl ad to be aired tomorrow night. The ad promotes, without identifying, semaglutide, the compounded versions of … [Read more…]

AceLink Therapeutics Presents Interim Results from a Phase 2 Trial of the GCS Inhibitor AL01211 in Treatment-Naïve, Classic Male Fabry Disease Patients at the WORLD Symposium 2025

SAN FRANCISCO & SHANGHAI–(BUSINESS WIRE)–AceLink Therapeutics, Inc., a clinical-stage biotech company developing next-generation oral substrate reduction therapies (SRTs), presented interim data from its ongoing Phase 2 clinical study of AL01211 in treatment-naïve, classic male Fabry disease patients. These findings were highlighted in a late-breaking oral platform presentation at the 2025 WORLD Symposium in San Diego, … [Read more…]

CORRECTING and REPLACING In It Together: Chegg Partners With Organizations Around the World for Third Annual Global Student Mental Health Week

Initiative aims to normalize mental health conversations and empower students SANTA CLARA, Calif.–(BUSINESS WIRE)–Fifth paragraph of release dated January 29, 2025: Student Minds has been removed from the list of non-profits and organizations Chegg has partnered with for this year’s Global Student Mental Health Week. The updated release reads: IN IT TOGETHER: CHEGG PARTNERS WITH … [Read more…]

A Safe Choice Network, Offering Nationwide Access to Medication Abortions, Urges Women to Prepare for Possible Changes in Federal Policies by Ordering Pills in Advance

A Service Known as “Advance Provision” is Available Nationally Now SAN FRANCISCO–(BUSINESS WIRE)–A Safe Choice, a referral network of medical doctors who provide safe and effective medication abortion services nationwide, is urging women to order pills in advance, in light of current legal and political efforts to restrict access to reproductive healthcare. A medication abortion, … [Read more…]

Bamboo Health Welcomes Ross Armstrong as Chief Commercial Officer

Armstrong’s leadership will drive client-focused innovation, scale solutions and enhance whole-person care LOUISVILLE, Ky.–(BUSINESS WIRE)–Bamboo Health™, the leader in Real-Time Care Intelligence™, today announced that Ross Armstrong has joined the company as its new Chief Commercial Officer. With a proven track record of driving innovation and impactful results across multiple healthcare sectors, Armstrong will play … [Read more…]

Bruker Announces Date and Time of Fourth Quarter 2024 Earnings Release and Webcast

BILLERICA, Mass.–(BUSINESS WIRE)–$BRKR #BRKR—Bruker Corporation (Nasdaq: BRKR) today announced it will report fourth quarter and fiscal year 2024 financial results before market opening on Thursday, February 13, 2025. The Company will host a conference call and webcast at 8:30 a.m. Eastern Standard Time to discuss the results and current business trends. To listen to the … [Read more…]

New England Journal of Medicine Publishes New Data for Genentech’s Gazyva Which Shows Superiority Over Standard Therapy in People With Active Lupus Nephritis

– Nearly half of patients on Gazyva plus standard therapy achieved a complete renal response (CRR), with a statistically significant and clinically meaningful improvement, compared to standard treatment alone – – Analysis showed consistent CRR benefit across patient subgroups highlighting potential to treat a broad patient population with high unmet need – – Gazyva is … [Read more…]

RenovoRx Announces Pricing of $12.1 Million Underwritten Public Offering of Common Stock

MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath®, a novel, FDA-cleared delivery platform, today announced the pricing of a firm commitment, underwritten public offering of 11,523,810 shares of its common stock at a price to the public of $1.05 per … [Read more…]

Prime Healthcare Services, Inc. Schedules 2024 4th Quarter Earnings Conference Call

ONTARIO, Calif.–(BUSINESS WIRE)–Prime Healthcare Services will report earnings the morning of March 17th to be followed by a conference call at 2:00 p.m. (ET) to discuss the reported results. To pre-register for the call, please email EGarcia27@primehealthcare.com to facilitate attaining your individual pin that will allow direct access to the call. Please note it is … [Read more…]

MediPrint Ophthalmics Advances Glaucoma Program, Expands Patent Portfolio, and Prepares for Key Industry Presentation

SAN DIEGO–(BUSINESS WIRE)–MediPrint® Ophthalmics, a clinical-stage ophthalmic drug delivery company, continues to advance its innovative glaucoma program following the successful completion of its Phase 2b clinical trial for LL-BMT1. As the company progresses towards the next phase of development, MediPrint anticipates meeting with the U.S. Food and Drug Administration (FDA) in 2025 to discuss preparations … [Read more…]